EU/3/16/1634

About

Please note that this product was withdrawn from the Community Register of designated Orphan Medicinal Products in October 2019 on request of the Sponsor. 

The sponsorship was transferred to Immune Design Ltd, United Kindom, in August 2016.


On 21 March 2016, orphan designation (EU/3/16/1634) was granted by the European Commission to Pharm Research Associates (UK) Limited, United Kingdom, for glucopyranosyl lipid A stable emulsion and recombinant New York oesophageal squamous cell carcinoma-1 protein (NY-ESO-1) for the treatment of soft tissue sarcoma.

Key facts

Active substance
Glucopyranosyl lipid A stable emulsion and recombinant New York oesophageal squamous cell carcinoma-1 protein
Disease / condition
Treatment of soft tissue sarcoma
Date of first decision
21/03/2016
Outcome
Withdrawn
EU designation number
EU/3/16/1634

Review of designation

The Committee for Orphan Medicinal Products reviews the orphan designation of a product if it is approved for marketing authorisation.

Sponsor's contact details

Immune Design Ltd
21 Holborn Viaduct
London EC1A 2DY
United Kingdom
Tel. +44 (0) 2031 005 102
Contact us

Patients' organisations

For contact details of patients’ organisations whose activities are targeted at rare diseases, see:

  • European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.

  • Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.

How useful was this page?

Add your rating